Cite
Tisdale RL, Ma I, Vail D, et al. Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures. JAMA Netw Open. 2021;4(6):e2113969doi: 10.1001/jamanetworkopen.2021.13969.
Tisdale, R. L., Ma, I., Vail, D., Bhattacharya, J., Goldhaber-Fiebert, J. D., Heidenreich, P. A., & Sandhu, A. T. (2021). Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures. JAMA network open, 4(6), e2113969. https://doi.org/10.1001/jamanetworkopen.2021.13969
Tisdale, Rebecca L, et al. "Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures." JAMA network open vol. 4,6 (2021): e2113969. doi: https://doi.org/10.1001/jamanetworkopen.2021.13969
Tisdale RL, Ma I, Vail D, Bhattacharya J, Goldhaber-Fiebert JD, Heidenreich PA, Sandhu AT. Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures. JAMA Netw Open. 2021 Jun 01;4(6):e2113969. doi: 10.1001/jamanetworkopen.2021.13969. PMID: 34143189; PMCID: PMC8214163.
Copy
Download .nbib